Dominari (NASDAQ:DOMH) Shares Down 1.4% – Time to Sell?

Dominari Holdings Inc. (NASDAQ:DOMH)’s share price was down 1.4% during mid-day trading on Monday . The company traded as low as $2.77 and last traded at $2.79. 19,826 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 121,804 shares. The stock had previously closed at $2.83.

Wall Street Analyst Weigh In

DOMH has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Dominari in a research report on Monday, July 6th. Wall Street Zen raised shares of Dominari from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Dominari Stock Performance

The firm has a market cap of $63.08 million, a P/E ratio of -0.69 and a beta of 0.84. The stock has a fifty day simple moving average of $3.22 and a 200 day simple moving average of $3.41.

Dominari (NASDAQ:DOMH) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($2.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($1.94). The business had revenue of $35.81 million for the quarter, compared to the consensus estimate of $35.80 million. Dominari had a negative net margin of 31.37% and a negative return on equity of 206.20%.

Dominari Dividend Announcement

The firm also recently announced a special dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were given a $0.31 dividend. The ex-dividend date of this dividend was Friday, May 15th.

Hedge Funds Weigh In On Dominari

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Creek Drive Management Group LLC purchased a new stake in shares of Dominari during the 4th quarter valued at about $1,861,000. PFG Investments LLC purchased a new position in shares of Dominari during the fourth quarter valued at approximately $53,000. Connective Capital Management LLC raised its holdings in shares of Dominari by 26.2% during the third quarter. Connective Capital Management LLC now owns 335,273 shares of the company’s stock valued at $2,377,000 after purchasing an additional 69,545 shares during the last quarter. Two Sigma Investments LP bought a new position in Dominari during the third quarter valued at approximately $771,000. Finally, Geode Capital Management LLC lifted its position in Dominari by 8.9% during the fourth quarter. Geode Capital Management LLC now owns 88,293 shares of the company’s stock valued at $437,000 after purchasing an additional 7,244 shares during the period. Institutional investors own 42.48% of the company’s stock.

About Dominari

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.